MedTrace Logo

Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease

NCT06655493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 756

Last updated 2025-10-21

No results posted yet for this study

Summary

This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease) with/without kidney disease.

The aim of the study is to assess the number of people with high levels of systemic inflammation among Middle East people with cardiovascular with/without kidney disease. Systemic inflammation means that it occurs throughout the body.

Participation in this study only requires a single visit at the clinic/hospital/medical institution. Participants will continue their normal care and will not get any treatment as part of this study.

Conditions

  • Systemic Inflammation (hsCRP)

Interventions

OTHER

No treatment given

Participants will continue their normal care and will not get any treatment as part of this study.

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency (dept. 2834) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-22
Primary Completion
2025-08-28
Completion
2025-08-28

Countries

  • Saudi Arabia
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655493 on ClinicalTrials.gov